UPDATED Mar 10, 2024
Companies in consumer staple industries including durables, food, beverage, tobacco, and household and personal products.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
---|---|---|---|---|---|---|---|---|---|---|
JNJJohnson & Johnson | US$159.02 | 0% | -1.7% | US$384.2b | US$173.69 | PE28.8x | E9.3% | 3.0% | ||
JNJCLJohnson & Johnson | US$155,930.00 | 0% | -1.3% | US$384.2b | US$170,316.87 | PE28.8x | E9.3% | 3.0% | ||
MRKCLMerck | US$123,720.00 | 0% | 59.0% | US$312.8b | US$134,362.00 | PE856.9x | E24.7% | 2.5% | ||
MRKMerck | US$118.61 | 0% | 8.0% | US$312.8b | US$128.81 | PE856.9x | E24.7% | 2.5% | ||
PFEPfizer | US$26.92 | -9.7% | -45.3% | US$153.7b | US$32.35 | PE72x | E19.6% | 6.2% | ||
PFECLPfizer | US$26,442.00 | 0% | -36.5% | US$153.7b | US$31,779.73 | PE72x | E19.6% | 6.2% | ||
AMGNAmgen | US$255.16 | 0% | 0% | US$146.7b | US$283.03 | PE21.8x | E9.2% | 3.3% | ||
GILDGilead Sciences | US$65.55 | 0% | 0% | US$93.6b | US$76.20 | PE16.5x | E6.5% | 4.1% | ||
BIIBCLBiogen | US$261,090.00 | 0% | 0% | US$32.5b | US$350,420.92 | PE27.9x | E18.4% | n/a | ||
BIIBBiogen | US$245.00 | 0% | 0% | US$32.5b | US$328.83 | PE27.9x | E18.4% | n/a |